Making Strides Against Bladder Cancer

July is Bladder Cancer Awareness Month.

Bladder cancer is a common type of cancer in the United States. Approximately 79,030 people will be diagnosed with bladder cancer and some 16,000 people are expected to die from the disease in 2017, according to the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program (SEER).

The National Cancer Institute (NCI) explains that there are three types of bladder cancer. These cancers are named for the type of cells that become malignant: transitional cell carcinoma, which begins in cells in the innermost tissue layer of the bladder; squamous cell carcinoma, which begins in the squamous cells, and may form after long-term infection or irritation; and adenocarcinoma, which begins in glandular (secretory) cells that are found in the lining of the bladder.

Cancer that is in the lining of the bladder is called superficial bladder cancer. Cancer that has spread through the lining of the bladder and has invaded the muscle wall of the bladder or has spread to nearby organs and lymph nodes is called invasive bladder cancer.

Risk factors for bladder cancer include tobacco use, having a family history of the disease, exposure to certain chemicals in the workplace, drinking well water with high levels of arsenic, and having a history of bladder infections, according to the NCI.

About three out of four people survived five years or more after being diagnosed with bladder cancer between 2006 and 2012, according to federal statistics.

The AACR's mission is to prevent and cure all forms of cancer.

The American Association for Cancer Research (AACR) is a 501c3 registered nonprofit organization with offices at 615 Chestnut Street, 17th Floor, Philadelphia, PA 19106 | 215.440.9300